Profile data is unavailable for this security.
About the company
Adcock Ingram Holdings Limited is a South Africa-based healthcare company. The Company’s segments include Consumer, Over the Counter (OTC), Prescription, Hospital, and Other. The Consumer segment is engaged mainly in the fast-moving consumer goods (FMCG) space. Its OTC segment focuses on brands sold predominantly in pharmacies. Its Prescription segment markets products prescribed by medical practitioners, and specialized instruments and surgical products. Its Hospital segment supplies hospital and critical care products, including intravenous solutions, blood collection products and renal dialysis systems. Its Other segment include shared services and other support services, including regulatory services in India, as well as the investment in the joint venture and cash and bank overdraft balances which are managed on a central basis in Southern Africa.
- Revenue in ZAR (TTM)9.64bn
- Net income in ZAR814.01m
- Incorporated2007
- Employees2.44k
- LocationAdcock Ingram Holdings Ltd1 New Road, (c/o New Road & 7th Street)MIDRAND 1682South AfricaZAF
- Phone+27 116350000
- Fax+27 865530000
- Websitehttps://www.adcock.co.za/
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ScinoPharm Taiwan Ltd | 1.93bn | 226.30m | 10.35bn | 1.01k | 45.83 | 1.78 | 21.07 | 5.37 | 0.5084 | 0.5084 | 4.33 | 13.12 | 0.2871 | 1.27 | 6.63 | -- | 3.37 | 2.33 | 3.69 | 2.51 | 38.89 | 41.09 | 11.76 | 9.10 | 5.00 | -- | 0.0592 | 109.25 | -2.39 | -2.00 | -18.73 | -8.31 | 16.90 | -9.35 |
| Obio Technology Shanghai Corp Ltd | 635.10m | -622.30m | 10.36bn | 731.00 | -- | 2.20 | -- | 16.31 | -0.3834 | -0.3834 | 0.3915 | 2.89 | 0.1012 | 4.00 | 2.55 | 344,293.00 | -9.93 | 0.2246 | -11.17 | 0.2514 | -26.42 | 36.72 | -98.16 | 1.48 | 2.27 | -- | 0.104 | 0.00 | -29.69 | 35.88 | -425.90 | -- | 57.00 | -- |
| SeQuent Scientific Ltd | 3.08bn | 11.85m | 10.55bn | 1.20k | 916.97 | -- | 62.89 | 3.42 | 0.2137 | 0.2137 | 57.18 | -- | -- | -- | -- | 11,939,190.00 | -- | 1.09 | -- | 1.76 | 45.38 | 41.97 | 0.9902 | 1.18 | -- | 0.9009 | -- | 35.06 | -3.60 | 5.68 | 70.40 | -- | 6.96 | -- |
| Jiangsu Aidea Pharmaceutical Co Ltd | 1.03bn | -263.83m | 10.55bn | 476.00 | -- | 3.91 | -- | 10.23 | -0.2384 | -0.2384 | 0.9459 | 2.54 | 0.2193 | 0.9553 | 2.66 | 858,576.30 | -5.65 | -2.40 | -8.32 | -2.85 | 48.96 | 39.00 | -25.77 | -10.15 | 1.11 | -- | 0.3018 | -- | 68.44 | 8.24 | 38.75 | -- | -4.47 | -- |
| Supriya Lifescience Ltd | 1.35bn | 340.20m | 10.58bn | 448.00 | 31.16 | 5.41 | 28.04 | 7.84 | 19.54 | 19.54 | 77.55 | 112.56 | 0.6737 | 2.01 | 6.56 | 13,950,510.00 | 16.98 | 19.08 | 18.38 | 24.04 | 66.81 | 57.12 | 25.20 | 24.71 | 4.05 | 111.46 | 0.006 | 2.88 | 23.74 | 15.47 | 32.56 | 24.75 | 83.79 | -- |
| Pharmanutra SpA | 2.05bn | 279.24m | 10.63bn | 112.00 | 37.79 | 9.99 | 31.17 | 5.17 | 1.51 | 1.51 | 11.09 | 5.70 | 0.9827 | 0.6257 | 4.40 | 1,015,648.00 | 13.36 | 18.39 | 17.76 | 24.80 | 95.63 | 96.36 | 13.59 | 17.77 | 1.84 | 41.91 | 0.3305 | 52.51 | 21.13 | 16.51 | -14.73 | 8.44 | 75.71 | 11.20 |
| Zhejiang Starry Pharmaceutical Co Ltd | 5.98bn | 35.05m | 10.63bn | 1.85k | 191.36 | 1.58 | -- | 1.78 | 0.0502 | 0.0502 | 5.72 | 6.08 | 0.4094 | 1.74 | 6.76 | 1,284,337.00 | 0.2471 | 3.30 | 0.4806 | 5.97 | 21.35 | 32.35 | 0.6036 | 8.21 | 0.4855 | 1.21 | 0.4994 | 53.08 | 3.04 | 19.78 | 158.32 | -13.94 | 10.39 | -- |
| Adcock Ingram Holdings Limited | 9.64bn | 814.01m | 10.66bn | 2.44k | 12.57 | 1.61 | -- | 1.11 | 5.26 | 5.26 | 62.36 | 40.94 | 1.16 | 2.57 | 4.50 | 3,958,591.00 | 9.80 | 10.24 | 13.97 | 14.44 | 33.38 | 30.34 | 8.44 | 9.05 | 0.9267 | -- | 0.0493 | 41.41 | 5.60 | 6.38 | -9.39 | 3.37 | -9.93 | 6.58 |
| Boiron SA | 9.28bn | 456.33m | 10.70bn | 2.79k | 23.20 | 1.47 | 13.12 | 1.15 | 1.36 | 1.36 | 27.74 | 21.48 | 0.7352 | 1.29 | 6.19 | 171,427.80 | 3.42 | 4.59 | 4.21 | 5.76 | 72.84 | 74.02 | 4.65 | 6.80 | 1.37 | -- | 0.0383 | 53.86 | -7.67 | -3.98 | -19.80 | -9.01 | -17.68 | -1.42 |
| ASP Isotopes Inc | 41.86m | -493.13m | 10.81bn | 76.00 | -- | 39.44 | -- | 258.22 | -0.628 | -0.628 | 0.0549 | 0.2112 | 0.068 | -- | -- | 30,206.32 | -71.81 | -- | -89.44 | -- | 36.54 | -- | -1,055.85 | -- | -- | -8.11 | 0.6748 | -- | -- | -- | -229.34 | -- | -- | -- |
| Shandong Boan Biotechnology Co Ltd | 1.81bn | 155.77m | 10.99bn | 777.00 | 67.03 | 2.98 | 33.25 | 6.06 | 0.1305 | 0.1305 | 1.52 | 2.94 | 0.3069 | 1.10 | 2.60 | 952,245.10 | 2.63 | -- | 3.43 | -- | 74.10 | -- | 8.59 | -- | 1.03 | 4.01 | 0.3369 | -- | 19.80 | -- | 64.02 | -- | -- | -- |
Data as of Nov 14 2024. Currency figures normalised to Adcock Ingram Holdings Ltd's reporting currency: South African Rand ZAR
13.05%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| Public Investment Corporation (SOC) Ltd.as of 30 Jun 2023 | 15.34m | 9.04% |
| Old Mutual Customised Solutions (Pty) Ltd.as of 30 Jun 2024 | 1.22m | 0.72% |
| Dimensional Fund Advisors LPas of 03 Oct 2024 | 1.17m | 0.69% |
| BlackRock Fund Advisorsas of 03 Oct 2024 | 909.79k | 0.54% |
| Abax Investments (Pty) Ltd.as of 30 Sep 2024 | 840.00k | 0.50% |
| ClucasGray Investment Management (Pty) Ltd.as of 29 Mar 2024 | 820.08k | 0.48% |
| Merchant West Investments (Pty) Ltd.as of 30 Aug 2024 | 603.38k | 0.36% |
| Centaur Asset Management Pty Ltd.as of 30 Sep 2024 | 567.79k | 0.34% |
| Camissa Asset Management Pty Ltd.as of 31 Mar 2024 | 376.04k | 0.22% |
| SSgA Funds Management, Inc.as of 03 Oct 2024 | 298.05k | 0.18% |
More ▼
Data from 29 Mar 2024 - 06 Nov 2024Source: FactSet Research Systems Inc.
